Symbols / WOK Stock $0.10 -0.50% WORK Medical Technology Group LTD

Healthcare • Medical Devices • China • NCM
WOK (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Shuang Wu
Exch · Country NCM · China
Market Cap 129.59K
Enterprise Value 5.28M
Income -1.07M
Sales 9.85M
FCF (ttm) -5.52M
Book/sh 17.70
Cash/sh 3.35
Employees 238
Insider 10d —
IPO Aug 23, 2024
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S 0.01
P/B 0.01
P/C —
EV/EBITDA -3.35
EV/Sales 0.54
Quick Ratio 0.39
Current Ratio 1.71
Debt/Eq 30.32
LT Debt/Eq —
EPS (ttm) -400.00
EPS next Y —
EPS Growth —
Revenue Growth -14.40%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA -4.49%
ROE -6.45%
ROIC —
Gross Margin 23.81%
Oper. Margin -17.52%
Profit Margin -10.89%
Shs Outstand 1.22M
Shs Float 894.26K
Insider Own 20.05%
Instit Own 0.01%
Short Float 9.69%
Short Ratio 0.00
Short Interest 118.00K
52W High 9,300.00
vs 52W High -100.00%
52W Low 0.08
vs 52W Low 19.05%
Beta —
Impl. Vol. —
Rel Volume 0.84
Avg Volume 44.97M
Volume 37.92M
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.10
Price $0.10
Change -0.50%
About

WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People's Republic of China and internationally. The company offers medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, yankauer suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half masks; visualized prostatic dilatation catheters; and nebulizer kits, SPO2 sensors, nasogastric tubes, personal protective equipment, hygiene and skincare products, cleaners for household use, and non-powered air-purifying particle respirators. It also engages in the research and development of biological and medical technology; and sale of chemical products. The company serves hospitals, pharmacies, and medical institutions. It exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania. WORK Medical Technology Group LTD has strategic cooperation agreement with Shanghai Novabioplus Biotechnology Co., Ltd. to develop data-model-application trinity for intelligent medical models. WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.10
Latest analyst target
3. DCF / Fair value
$-81.52
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.10
Low
—
High
—
Mean
—
News
RSS: Latest WOK news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Total Revenue
9.85
-14.41%
11.51
-15.18%
13.57
-31.18%
19.71
Operating Revenue
9.83
-13.85%
11.41
-14.94%
13.41
-31.12%
19.47
Cost Of Revenue
7.50
-13.13%
8.64
-8.33%
9.42
-38.38%
15.29
Reconciled Cost Of Revenue
7.50
-13.13%
8.64
-8.33%
9.42
-38.38%
15.29
Gross Profit
2.34
-18.25%
2.87
-30.77%
4.14
-6.24%
4.42
Operating Expense
3.24
-50.66%
6.57
+79.60%
3.66
+40.97%
2.59
Research And Development
0.44
+43.90%
0.30
+0.29%
0.30
+64.03%
0.18
Selling General And Administration
4.41
-33.36%
6.61
+92.79%
3.43
-4.66%
3.60
Selling And Marketing Expense
2.08
+1.23%
2.05
+30.98%
1.57
+51.78%
1.03
General And Administrative Expense
2.33
-48.94%
4.56
+144.83%
1.86
-27.39%
2.56
Other Gand A
2.33
-48.94%
4.56
+144.83%
1.86
-27.39%
2.56
Other Operating Expenses
-1.60
-361.82%
-0.35
-366.88%
-0.07
+93.74%
-1.19
Total Expenses
10.74
-29.34%
15.21
+16.25%
13.08
-26.87%
17.89
Operating Income
-0.90
+75.79%
-3.70
-860.31%
0.49
-73.34%
1.82
EBITDA
0.34
+120.30%
-1.70
-180.60%
2.11
-55.42%
4.72
Normalized EBITDA
0.34
+120.30%
-1.70
-180.60%
2.11
-55.42%
4.72
Reconciled Depreciation
0.92
-34.55%
1.41
-12.02%
1.60
-50.80%
3.26
EBIT
-0.58
+81.39%
-3.11
-717.76%
0.50
-65.69%
1.47
Total Unusual Items
—
—
—
—
Total Unusual Items Excluding Goodwill
—
—
—
—
Special Income Charges
—
—
—
—
Impairment Of Capital Assets
—
—
—
—
Net Income
-1.07
+69.28%
-3.49
-3217.31%
0.11
-87.05%
0.87
Pretax Income
-1.08
+70.48%
-3.67
-3420.71%
0.11
-90.09%
1.11
Net Non Operating Interest Income Expense
-0.32
+41.04%
-0.55
-48.60%
-0.37
-4.65%
-0.35
Interest Expense Non Operating
0.50
-9.69%
0.56
+41.97%
0.39
+11.27%
0.35
Net Interest Income
-0.32
+41.04%
-0.55
-48.60%
-0.37
-4.65%
-0.35
Interest Expense
0.50
-9.69%
0.56
+41.97%
0.39
+11.27%
0.35
Interest Income Non Operating
0.18
+1449.26%
0.01
-53.86%
0.03
+1190.86%
0.00
Interest Income
0.18
+1449.26%
0.01
-53.86%
0.03
+1190.86%
0.00
Other Income Expense
0.14
-76.61%
0.58
+6717.40%
-0.01
+97.57%
-0.36
Other Non Operating Income Expenses
0.14
-76.61%
0.58
+6717.40%
-0.01
+97.57%
-0.36
Tax Provision
0.12
+195.02%
-0.13
-366.54%
0.05
-72.26%
0.17
Tax Rate For Calcs
0.00
+635.29%
0.00
-86.40%
0.00
+64.47%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-1.20
+66.08%
-3.54
-5685.74%
0.06
-93.29%
0.94
Net Income From Continuing Operation Net Minority Interest
-1.07
+69.28%
-3.49
-3217.31%
0.11
-87.05%
0.87
Net Income From Continuing And Discontinued Operation
-1.07
+69.28%
-3.49
-3217.31%
0.11
-87.05%
0.87
Net Income Continuous Operations
-1.20
+66.08%
-3.54
-5685.74%
0.06
-93.29%
0.94
Minority Interests
0.13
+166.90%
0.05
-1.14%
0.05
+161.64%
-0.08
Normalized Income
-1.07
+69.28%
-3.49
-3217.31%
0.11
-87.05%
0.87
Net Income Common Stockholders
-1.07
+69.28%
-3.49
-3217.31%
0.11
-87.05%
0.87
Diluted EPS
—
-2,700.00
-3594.60%
77.26
-86.16%
558.20
Basic EPS
—
-2,700.00
-3594.60%
77.26
-87.05%
596.70
Basic Average Shares
—
0.00
-10.83%
0.00
+0.00%
0.00
Diluted Average Shares
—
0.00
-10.83%
0.00
-6.45%
0.00
Diluted NI Availto Com Stockholders
-1.07
+69.28%
-3.49
-3217.31%
0.11
-87.05%
0.87
Excise Taxes
—
—
—
—
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Total Assets
33.16
-8.54%
36.25
+21.00%
29.96
+17.30%
25.54
Current Assets
20.46
-1.79%
20.83
-5.98%
22.15
+33.36%
16.61
Cash Cash Equivalents And Short Term Investments
4.09
-37.65%
6.56
+310.85%
1.60
+118.29%
0.73
Cash And Cash Equivalents
4.09
-37.65%
6.56
+310.85%
1.60
+118.29%
0.73
Receivables
12.45
+116.37%
5.75
-47.62%
10.99
+78.66%
6.15
Accounts Receivable
0.62
-62.65%
1.65
-50.52%
3.33
+1.35%
3.29
Gross Accounts Receivable
0.69
-74.09%
2.65
-38.94%
4.34
-6.23%
4.63
Allowance For Doubtful Accounts Receivable
-0.07
+92.87%
-1.00
+0.77%
-1.01
+24.76%
-1.34
Receivables Adjustments Allowances
0.00
+100.00%
-0.43
-21.08%
-0.35
+4.80%
-0.37
Other Receivables
—
0.59
-3.30%
0.61
+24.49%
0.49
Loans Receivable
1.05
-58.23%
2.51
-43.75%
4.46
+72.99%
2.58
Inventory
2.46
-22.88%
3.18
-31.09%
4.62
+6.01%
4.36
Raw Materials
0.53
-12.87%
0.61
-18.44%
0.74
+17.84%
0.63
Work In Process
0.88
-40.00%
1.46
-27.89%
2.03
+16.20%
1.75
Finished Goods
1.40
+2.81%
1.37
-34.59%
2.09
-5.48%
2.21
Prepaid Assets
1.42
-70.69%
4.84
+38.54%
3.49
-25.69%
4.70
Current Deferred Assets
—
0.00
-100.00%
1.36
+118.80%
0.62
Restricted Cash
0.00
-100.00%
0.40
+871.18%
0.04
-2.50%
0.04
Other Current Assets
0.04
-53.85%
0.09
+52.61%
0.06
+569.16%
0.01
Total Non Current Assets
12.70
-17.65%
15.42
+97.58%
7.81
-12.59%
8.93
Net PPE
11.74
-17.69%
14.27
+111.64%
6.74
-15.54%
7.98
Gross PPE
18.58
-9.54%
20.54
+14.82%
17.89
-4.41%
18.71
Accumulated Depreciation
-6.84
-9.00%
-6.27
+43.72%
-11.15
-3.87%
-10.73
Properties
0.00
0.00
0.00
-100.00%
5.53
Buildings And Improvements
11.78
-1.13%
11.92
+120.81%
5.40
-2.46%
5.53
Machinery Furniture Equipment
5.64
-1.49%
5.73
-53.71%
12.38
-5.43%
13.09
Construction In Progress
1.13
-61.02%
2.89
0.00
—
Other Properties
0.03
—
0.11
+23.64%
0.09
Goodwill And Other Intangible Assets
0.96
-8.14%
1.04
+4.57%
1.00
+5.10%
0.95
Other Intangible Assets
0.96
-8.14%
1.04
+4.57%
1.00
+5.10%
0.95
Non Current Deferred Assets
0.00
-100.00%
0.11
+68.85%
0.07
0.00
Non Current Deferred Taxes Assets
0.00
-100.00%
0.11
+68.85%
0.07
0.00
Total Liabilities Net Minority Interest
11.99
-40.58%
20.18
+6.36%
18.97
+32.21%
14.35
Current Liabilities
11.97
-40.68%
20.18
+6.64%
18.92
+32.73%
14.26
Payables And Accrued Expenses
5.17
-15.07%
6.09
-33.10%
9.10
+25.02%
7.28
Payables
5.17
-15.07%
6.09
-33.10%
9.10
+25.02%
7.28
Accounts Payable
1.72
+15.19%
1.50
-62.21%
3.96
+23.70%
3.20
Other Payable
0.96
-16.43%
1.15
-61.95%
3.01
+74.29%
1.73
Pensionand Other Post Retirement Benefit Plans Current
—
—
—
0.51
Total Tax Payable
2.48
+4.43%
2.37
+11.58%
2.13
+23.35%
1.72
Income Tax Payable
0.50
-1.42%
0.51
-30.93%
0.74
+18.89%
0.62
Current Debt And Capital Lease Obligation
6.40
-52.49%
13.47
+48.87%
9.05
+45.13%
6.23
Current Debt
6.39
-52.54%
13.47
+49.69%
9.00
+44.77%
6.21
Other Current Borrowings
—
0.14
-8.40%
0.16
-35.09%
0.24
Current Capital Lease Obligation
0.01
0.00
-100.00%
0.05
+166.61%
0.02
Current Deferred Liabilities
0.40
-35.65%
0.63
-19.44%
0.78
+4.31%
0.74
Current Deferred Revenue
0.40
-35.65%
0.63
-19.44%
0.78
+4.31%
0.74
Total Non Current Liabilities Net Minority Interest
0.02
0.00
-100.00%
0.05
-46.69%
0.09
Long Term Debt And Capital Lease Obligation
0.02
0.00
-100.00%
0.05
-26.82%
0.07
Long Term Capital Lease Obligation
0.02
0.00
-100.00%
0.05
-26.82%
0.07
Non Current Deferred Liabilities
0.00
—
0.00
-100.00%
0.03
Non Current Deferred Taxes Liabilities
0.00
—
0.00
-100.00%
0.03
Stockholders Equity
18.34
+39.08%
13.19
+33.51%
9.88
-1.25%
10.00
Common Stock Equity
18.34
+39.08%
13.19
+33.51%
9.88
-1.25%
10.00
Capital Stock
0.05
+609.92%
0.01
+16.74%
0.01
+0.00%
0.01
Common Stock
0.05
+609.92%
0.01
+16.74%
0.01
+0.00%
0.01
Share Issued
0.01
+610.01%
0.00
+0.62%
0.00
+0.00%
0.00
Ordinary Shares Number
0.01
+610.01%
0.00
+0.62%
0.00
+0.00%
0.00
Additional Paid In Capital
13.04
+97.10%
6.62
+7684.31%
0.09
+0.00%
0.09
Retained Earnings
4.96
-18.38%
6.08
-36.58%
9.58
+0.79%
9.51
Gains Losses Not Affecting Retained Earnings
0.29
-40.76%
0.49
+133.21%
0.21
-48.67%
0.41
Minority Interest
2.83
-2.03%
2.88
+159.94%
1.11
-6.74%
1.19
Other Equity Adjustments
0.29
-40.76%
0.49
+133.21%
0.21
-48.67%
0.41
Total Equity Gross Minority Interest
21.16
+31.70%
16.07
+46.28%
10.99
-1.83%
11.19
Total Capitalization
18.34
+39.08%
13.19
+33.51%
9.88
-1.25%
10.00
Working Capital
8.48
+1211.17%
0.65
-79.97%
3.23
+37.21%
2.35
Invested Capital
24.73
-7.21%
26.65
+41.22%
18.87
+16.39%
16.21
Total Debt
6.42
-52.35%
13.47
+48.05%
9.10
+44.35%
6.30
Net Debt
2.30
-66.67%
6.91
-6.64%
7.40
+34.96%
5.48
Capital Lease Obligations
0.03
0.00
-100.00%
0.10
+14.46%
0.09
Net Tangible Assets
17.38
+43.14%
12.14
+36.77%
8.88
-1.91%
9.05
Tangible Book Value
17.38
+43.14%
12.14
+36.77%
8.88
-1.91%
9.05
Duefrom Related Parties Current
10.79
+654.06%
1.43
-51.22%
2.93
+1728.00%
0.16
Dueto Related Parties Current
0.01
-98.81%
1.07
+26454.92%
0.00
-99.35%
0.63
Inventories Adjustments Allowances
-0.36
-41.09%
-0.25
-4.29%
-0.24
-5.26%
-0.23
Line Of Credit
6.39
-52.03%
13.32
+50.71%
8.84
+47.97%
5.97
Other Equity Interest
-0.01
+0.00%
-0.01
+0.00%
-0.01
+0.00%
-0.01
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Operating Cash Flow
6.24
+380.25%
-2.23
-200.83%
2.21
+197.82%
-2.26
Cash Flow From Continuing Operating Activities
6.24
+380.25%
-2.23
-200.83%
2.21
+197.82%
-2.26
Net Income From Continuing Operations
-1.20
+66.08%
-3.54
-5685.74%
0.06
-93.29%
0.94
Depreciation Amortization Depletion
0.92
-34.55%
1.41
-12.02%
1.60
-50.80%
3.26
Depreciation And Amortization
0.92
-34.55%
1.41
-12.02%
1.60
-50.80%
3.26
Other Non Cash Items
-0.16
—
—
—
Provisionand Write Offof Assets
-0.16
-1380.28%
0.01
-91.87%
0.15
-86.52%
1.11
Asset Impairment Charge
0.11
+13758.14%
0.00
-95.84%
0.02
+115.61%
-0.12
Deferred Tax
0.11
+341.40%
-0.05
+51.29%
-0.09
+69.89%
-0.31
Deferred Income Tax
0.11
+341.40%
-0.05
+51.29%
-0.09
+69.89%
-0.31
Operating Gains Losses
0.18
+319.98%
0.04
+425.45%
0.01
+174.41%
-0.01
Gain Loss On Sale Of PPE
0.18
+319.68%
0.04
+425.45%
0.01
+174.41%
-0.01
Change In Working Capital
6.44
+6091.14%
-0.11
-123.28%
0.46
+106.48%
-7.13
Change In Receivables
1.02
-43.67%
1.82
+1475.79%
-0.13
+96.67%
-3.96
Changes In Account Receivables
1.02
-43.67%
1.82
+1475.79%
-0.13
+96.67%
-3.96
Change In Inventory
0.57
-63.94%
1.58
+493.66%
-0.40
-119.50%
2.05
Change In Prepaid Assets
6.23
+911.77%
-0.77
-133.84%
2.27
+687.85%
-0.39
Change In Payables And Accrued Expense
0.21
+104.92%
-4.33
-260.96%
2.69
+155.75%
-4.82
Change In Accrued Expense
-0.03
+97.87%
-1.52
-190.30%
1.69
+84.06%
0.92
Change In Payable
0.25
+108.75%
-2.80
-380.13%
1.00
+117.44%
-5.74
Change In Account Payable
0.25
+109.61%
-2.55
-395.39%
0.86
+114.85%
-5.82
Change In Other Working Capital
-1.59
-199.37%
1.60
+140.87%
-3.91
-49511.06%
-0.01
Change In Other Current Liabilities
-0.01
-187.73%
-0.00
+96.08%
-0.05
-893.00%
-0.01
Investing Cash Flow
-7.61
+16.07%
-9.06
-1453.92%
-0.58
+56.70%
-1.35
Cash Flow From Continuing Investing Activities
-7.61
+16.07%
-9.06
-1453.92%
-0.58
+56.70%
-1.35
Net PPE Purchase And Sale
-0.86
+90.48%
-9.03
-1883.08%
-0.46
+67.72%
-1.41
Purchase Of PPE
-1.33
+85.56%
-9.23
-1925.75%
-0.46
+77.37%
-2.01
Sale Of PPE
0.47
+143.37%
0.19
0.00
-100.00%
0.60
Capital Expenditure
-1.33
+85.61%
-9.26
-1487.24%
-0.58
+71.02%
-2.01
Net Investment Purchase And Sale
—
—
—
—
Purchase Of Investment
—
—
—
—
Net Business Purchase And Sale
-0.09
0.00
0.00
-100.00%
0.06
Purchase Of Business
-0.09
0.00
0.00
—
Gain Loss On Sale Of Business
0.00
0.00
0.00
—
Net Intangibles Purchase And Sale
0.00
+100.00%
-0.03
+73.96%
-0.13
0.00
Purchase Of Intangibles
0.00
+100.00%
-0.03
+73.96%
-0.13
0.00
Net Other Investing Changes
-6.66
—
—
—
Financing Cash Flow
-0.90
-105.74%
15.66
+2248.57%
-0.73
-120.43%
3.57
Cash Flow From Continuing Financing Activities
-0.90
-105.74%
15.66
+2248.57%
-0.73
-120.43%
3.57
Net Issuance Payments Of Debt
-5.79
-650.74%
1.05
+119.99%
-5.26
+45.70%
-9.69
Issuance Of Debt
18.82
+16.66%
16.13
+76.65%
9.13
+13.04%
8.08
Repayment Of Debt
-24.61
-63.23%
-15.08
-4.74%
-14.39
+19.00%
-17.77
Long Term Debt Issuance
0.86
-68.52%
2.73
+11505.46%
0.02
-97.16%
0.83
Long Term Debt Payments
0.00
+100.00%
-1.13
+58.38%
-2.72
-164.30%
-1.03
Net Long Term Debt Issuance
0.86
-46.23%
1.60
+159.28%
-2.70
-1239.56%
-0.20
Short Term Debt Issuance
17.95
+34.04%
13.39
+47.08%
9.11
+25.64%
7.25
Short Term Debt Payments
-24.61
-76.50%
-13.94
-19.48%
-11.67
+30.29%
-16.74
Net Short Term Debt Issuance
-6.66
-1112.86%
-0.55
+78.60%
-2.56
+73.00%
-9.49
Net Common Stock Issuance
6.90
-6.41%
7.37
0.00
0.00
Net Other Financing Charges
-2.00
-127.72%
7.23
+59.44%
4.54
-65.80%
13.26
Changes In Cash
-2.26
-151.81%
4.36
+386.22%
0.90
+2350.47%
-0.04
Effect Of Exchange Rate Changes
-0.21
-137.33%
0.56
+1740.86%
-0.03
+43.41%
-0.06
Beginning Cash Position
6.56
+300.52%
1.64
+111.69%
0.77
-11.42%
0.87
End Cash Position
4.09
-37.65%
6.56
+300.52%
1.64
+111.69%
0.77
Free Cash Flow
4.91
+142.76%
-11.49
-806.24%
1.63
+138.08%
-4.27
Interest Paid Supplemental Data
0.51
-6.48%
0.54
+74.26%
0.31
-0.08%
0.31
Income Tax Paid Supplemental Data
0.01
-18.75%
0.01
-93.77%
0.16
-52.90%
0.34
Change In Income Tax Payable
0.00
+100.00%
-0.25
-283.45%
0.14
+67.64%
0.08
Change In Tax Payable
0.00
+100.00%
-0.25
-283.45%
0.14
+67.64%
0.08
Common Stock Issuance
6.90
-6.41%
7.37
0.00
0.00
Issuance Of Capital Stock
6.90
-6.41%
7.37
0.00
0.00
Sale Of Business
—
0.00
0.00
-100.00%
0.06
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category